Stem cell treatment for neuropathy is early research. Laboratory and animal studies suggest mesenchymal stem cells release signals that may support nerve repair and calm inflammation, and very small early human studies have been reported. There are no large trials yet. It is not a proven cure.
What researchers are exploring
- Support for damaged nerve fibres and their blood supply
- Reducing inflammation around nerves
- Combination with PRP
Burning, numb or tingling feet for months? Get the free guide and a doctor review of your scan.
Who asks about it
- Diabetic neuropathy that persists despite good care
- Chemotherapy-induced neuropathy after cancer treatment ends, with the oncologist's agreement
- HIV-related neuropathy, alongside ongoing HIV care
Be realistic
Results vary and evidence is limited. A doctor should review your history, tests and current treatment first. It never replaces cancer or HIV treatment.
Recent research from Asia and beyond
| Country, year | Study | What it found |
|---|---|---|
| China, 2024 | Randomised trial with 8-year follow-up, *Stem Cell Res Ther* (PMID 39350270) | Bone marrow stem cell plus mononuclear cell therapy in type 2 diabetes reduced the overall rate of chronic diabetes complications and improved blood sugar control |
| Korea, 2026 | Phase 1 trial, *Stem Cells Transl Med* (PMID 42522265) | A cell therapy for an inherited neuropathy (Charcot-Marie-Tooth type 1) was safe, with early signs of possible benefit |
| China, 2026 | Meta-analysis, *Int J Low Extrem Wounds* (PMID 40530428) | Stem cells improved healing of small diabetic foot ulcers, a common problem in people with neuropathy |
| Japan, 2026 | Phase 1 trial, *Nat Med* (PMID 42481854) | Stem cell-derived nerve cells transplanted after spinal cord injury were feasible and safe, a milestone for nerve-repair research |
These are encouraging but early. None is yet a standard neuropathy treatment.